×
COMPASS Pathways Net Profit Margin 2019-2024 | CMPS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
COMPASS Pathways net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
COMPASS Pathways Net Profit Margin 2019-2024 | CMPS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
COMPASS Pathways net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$150.2B
Elevance Health (ELV)
$90.6B
CVS Health (CVS)
$82.1B
Cencora (COR)
$47.2B
DiDi Global (DIDIY)
$23.3B
Natera (NTRA)
$22.2B
ICON (ICLR)
$16.7B
BioMerieux (BMXMF)
$14.1B
Doximity (DOCS)
$14B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13.2B
Solventum (SOLV)
$12.9B
Avantor (AVTR)
$11.9B
CochLear (CHEOY)
$11.3B
Medpace Holdings (MEDP)
$10.5B
EUROFINS SCIENT (ERFSF)
$9.8B
HealthEquity (HQY)
$9.7B
Sonic Healthcare (SKHHY)
$8.7B
Charles River Laboratories (CRL)
$8.3B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.6B
Organon (OGN)
$4B
Sotera Health (SHC)
$3.8B
BrightSpring Health Services (BTSG)
$3.6B
Surgery Partners (SGRY)
$3.3B
Concentras Parent (CON)
$3B
GeneDx Holdings (WGS)
$2.8B
Alignment Healthcare (ALHC)
$2.8B
Teladoc Health (TDOC)
$2.2B
Ardent Health Partners (ARDT)
$2.1B